Related Experiment Video

Updated: Aug 7, 2026

Studying Effects of Cigarette Smoke on Pseudomonas Infection in Lung Epithelial Cells
09:15

Studying Effects of Cigarette Smoke on Pseudomonas Infection in Lung Epithelial Cells

Published on: May 11, 2020

Passive smoke exposure as a risk factor for airway complications during outpatient pediatric procedures

Dwight T Jones1, Neil Bhattacharyya

  • 1Department of Pediatric Otolaryngology, Brigham and Women's Hospital, 45 Francis Street, Boston, MA 02115, USA.

Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|July 4, 2006
PubMed

Insights

Children exposed to passive smoke (PSE) face higher risks of airway complications during outpatient mask anesthesia. This study found increased incidents of laryngospasm and airway obstruction in PSE patients.

Area of Science:

  • Pediatric Anesthesiology
  • Environmental Health
  • Respiratory Medicine

Background:

  • Passive smoke exposure (PSE) is a known respiratory irritant.
  • Understanding its impact on pediatric anesthesia is crucial for patient safety.

Purpose of the Study:

  • To determine if passive smoke exposure (PSE) increases airway complications in children undergoing outpatient mask anesthesia.

Main Methods:

  • Prospective cohort study of 405 children undergoing mask anesthesia.
  • Utilized American Thoracic Society questionnaire for environmental/respiratory factors.
  • Double-blinded assessment of airway events, comparing PSE and nonexposed groups.

Main Results:

  • 41.5% of children had passive smoke exposure (PSE).
  • PSE children showed significantly higher incidences of airway complications (P <= 0.005).
  • Intraoperative laryngospasm and airway obstruction were 4.9 and 2.8 times more likely in PSE patients, respectively.

Conclusions:

  • Passive smoke exposure significantly elevates the risk of anesthesia-related airway complications in pediatric outpatients.
  • Findings highlight the importance of screening for PSE in pediatric anesthesia.
Abstract

More Related Videos

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure08:17

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

Related Concept Videos

Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...